DRKS00024752尚未招募不适用
Franconian Longitudinal Study of Anorexia Nervosa in Adolescents - Basic Module - FRALANA - B
niversitätsklinikum Erlangen0 个研究点目标入组 42 人开始时间: 2021年4月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 10 Years 至 18 Years（—）
- 性别
- Female
入选标准
- •Anorexia Nervosa (AN) group: AN diagnosis according to ICD-10 criteria (F50.0 or F50.1), weight <10th BMI age percentile at start of participation; clinically depressed group (control group 1): diagnosis of a depressive disorder (F32.0-F32.2, F33) / adjustment disorder with depressive symptoms (F43.20-F43.22); healthy control group (control group 2): no diagnosis-worthy symptoms according to ICD-10 criteria. Control groups: BMI >10th age percentile.
排除标准
- •Acute psychotic symptoms; substance abuse / addiction; chronic physiological conditions (especially cardiovascular diseases); medication with tranquillizing effects (such as Benzodiazepines); learning disabilities; insufficient German skills to give informed consent. For the control groups: eating disorders.
研究者
相似试验
尚未招募
1 期
Franconian Longitudinal Study of Anorexia Nervosa in Adolescents - Intervention ModuleBody DissatisfactionF50.0F50.1Atypical anorexia nervosaAnorexia nervosaDRKS00024675niversitätsklinikum Erlangen Kinder- und Jugendabteilung für Psychische Gesundheit63
已完成
不适用
Ten year follow-up of Anorexia Nervosa patients: a course and outcome study.Anorexia10003018Anorexia NervosaNL-OMON34824niversitair Medisch Centrum Utrecht61
招募中
不适用
arrative therapy Intervention for Anorexia Nervosa: A Feasibility Study.Anorexia NervosaACTRN12622000620729Western Sydney University8
Unknown
不适用
Impact of the Addition of a Specific and Personalized Body Approach by Osteopathic Treatment in the Care of Adolescents With Anorexia Nervosa.Osteopathic MedicineAnorexia NervosaNCT04666415Institut Mutualiste Montsouris72
已完成
不适用
Insula-coil Deep TMS for Treatment Resistant Anorexia NervosaAnorexia NervosaNCT03144986Centre for Addiction and Mental Health9